Drug development

Genomics has the potential to significantly improve the efficacy of drugs and develop targeted therapies.

New Drug Combination Could Halt Fibrosis

A combination of drugs has potentially been uncovered that could halt the progression of fibrosis, a disease thought to be responsible for almost half of all deaths, according to a new study.

What Could You Do With 10,000 Immunomes?

A database of normal human immunity has been created by scientists at UC San Francisco, creating an instant comparison group to let researchers use in studies of the immune system and immune dysfunction.

GSK and 23andMe Agree to $300M Deal

Pharmaceutical giant GlaxoSmithKline has bought a $300 million stake in genetic DTC testing company 23andMe to help further their genetics-based drug discovery.